Beam Therapeutics (NASDAQ:BEAM) Trading Up 7.9% Following Analyst Upgrade
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was up 7.9% during trading on Tuesday after Scotiabank raised their price target on the stock from $24.00 to $25.00. Scotiabank currently has a sector perform rating on the stock. Beam Therapeutics traded as high as $26.84 and last traded at $27.09. Approximately 1,184,373 shares traded hands […]
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was up 7.9% during trading on Tuesday after Scotiabank raised their price target on the stock from $24.00 to $25.00. Scotiabank currently has a sector perform rating on the stock. Beam Therapeutics traded as high as $26.84 and last traded at $27.09. Approximately 1,184,373 shares traded hands […]
